Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia

被引:43
作者
Wallin, A [1 ]
Sjögren, M [1 ]
机构
[1] Gothenburg Univ, Sahlgrens Univ Hosp, Inst Clin Neurosci, SE-43180 Molndal, Sweden
关键词
dementia; subcortical; white matter; neurofilament; tau; albumin ratio;
D O I
10.1016/S0047-6374(01)00306-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The cerebrospinal fluid (CSF) levels of two cytoskeleton proteins, tau and the light subunit of neurofilament protein (NFL), both considered to reflect cerebral white-matter components, were investigated in a group of patients with a subtype of vascular dementia called 'subcortical white-matter dementia' (SWD). The group consisted of 25 demented patients with frontosubcortical brain syndromes, white-matter changes on computed tomography or magnetic resonance imaging and vascular disease or pronounced vascular risk factors. CSF-NFL was increased, whereas CSF-tau was normal, suggesting a differential involvement of the cytoskeleton in this patient group. The albumin ratio and the apolipoproteinE4 (ApoE4) allele status were also investigated. The albumin ratio was increased, indicating damage to the vessel walls with breakdown of the blood-brain barrier. No relationship was found between ApoE4 alleles and CSF levels of tau or NFL in this patient group. Besides presenting original data, the disease status of SWD is also discussed. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1937 / 1949
页数:13
相关论文
共 71 条
[1]  
Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
[2]   Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[3]  
[Anonymous], 1997, PRACTICAL STAT MED R
[4]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[5]   No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia [J].
Arai, H ;
Satoh-Nakagawa, T ;
Higuchi, M ;
Morikawa, Y ;
Miura, M ;
Kawakami, H ;
Seki, H ;
Takase, S ;
Sasaki, H .
NEUROSCIENCE LETTERS, 1998, 256 (03) :174-176
[6]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[7]   tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease? [J].
Blennow, K ;
Wallin, A ;
Agren, H ;
Spenger, C ;
Siegfried, J ;
Vanmechelen, E .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) :231-245
[8]   WHITE-MATTER LESIONS ON CT IN ALZHEIMER PATIENTS - RELATION TO CLINICAL SYMPTOMATOLOGY AND VASCULAR FACTORS [J].
BLENNOW, K ;
WALLIN, A ;
UHLEMANN, C ;
GOTTFRIES, CG .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (03) :187-193
[9]   Conceptual background to vascular cognitive impairment [J].
Bowler, JV ;
Steenhuis, R ;
Hachinski, V .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1999, 13 :S30-S37
[10]  
BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416